BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Heidari S, Kolahdouz-Mohammadi R, Khodaverdi S, Tajik N, Delbandi AA. Expression levels of MCP-1, HGF, and IGF-1 in endometriotic patients compared with non-endometriotic controls. BMC Womens Health 2021;21:422. [PMID: 34930225 DOI: 10.1186/s12905-021-01560-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Quan Q, Wu J, Yu M, Tang J. Immune micro-environment and drug analysis of peritoneal endometriosis based on epithelial-mesenchymal transition classification. Front Endocrinol (Lausanne) 2022;13:1035158. [PMID: 36523599 DOI: 10.3389/fendo.2022.1035158] [Reference Citation Analysis]
2 Heidari S, Kolahdouz-Mohammadi R, Khodaverdi S, Mohammadi T, Delbandi AA. Changes in MCP-1, HGF, and IGF-1 expression in endometrial stromal cells, PBMCs, and PFMCs of endometriotic women following 1,25(OH)2D3 treatment. J Cell Mol Med 2022. [PMID: 36259314 DOI: 10.1111/jcmm.17592] [Reference Citation Analysis]
3 Chung MS, Han SJ. Endometriosis-Associated Angiogenesis and Anti-angiogenic Therapy for Endometriosis. Front Glob Womens Health 2022;3:856316. [DOI: 10.3389/fgwh.2022.856316] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Gardella B, Dominoni M, Gritti A, Arrigo A, Antonucci S, Carletti GV, Musacchi V, Pietrocola G. Endometriosis pain and epithelial neutrophil activating peptide-78 levels. Sci Rep 2022;12:3227. [PMID: 35217683 DOI: 10.1038/s41598-022-07349-3] [Reference Citation Analysis]